⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Companies Prioritize Revenue Performance with AI, ISG Says
businesswire.com
III
ANAB
XACT
ORCL
CRM
SAP
WDAY
ACN
IBM
MSFT
GOOG
AMZN
ADBE
NOW
INTU
PAYX
FIS
PAYC
SNOW
DDOG
MDB
PLTR
AI
SMCI
NVDA
AMD
INTC
QCOM
META
NFLX
CMCSA
VZ
T
CSCO
HPQ
DELL
PANW
CRWD
FTNT
ZBRA
CDNS
SNPS
MRVL
NXPI
MU
WDC
AMAT
LRCX
KLAC
ASML
ADI
TXN
ON
MPWR
AEHR
ARM
AVGO
AMGN
GILD
BMY
PFE
MRK
JNJ
LLY
ABBV
MDT
ISRG
BIIB
REGN
AZN
NVS
RHHBY
XOM
CVX
SHEL
TCEHY
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
YY
BEKE
NIO
LI
XPEV
RIVN
LCID
TSLA
GM
F
STLA
TM
HMC
VWAGY
BMW
DAI
GE
HON
BA
LMT
RTX
GD
NOC
CAT
DE
AGCO
CNH
J
CHTR
CMCSK
TMUS
ATVI
EA
TTWO
DIS
FOX
PARA
WBD
LYV
AMC
NCLH
CCL
RCL
DAL
UAL
AAL
LUV
JBLU
ALK
MAR
HLT
IHG
WYNN
LVS
MGM
CHKP
Zscaler
AKR
VAR
NICE
BOARD
FORM
PIG
INFSPM
PERF
FULL
CAP
EVER
JED
OPT
XOXO
ELEV
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma
businesswire.com
BMY
Regenerative Medicine Market to Skyrocket to USD 403.86 Billion by 2032 Driven by Cell & Gene Therapy Breakthroughs, Stem Cell Advancements, and Multi-Indication Expansion
prnewswire.com
BMY
GILD
Bristol Myers Squibb to Host Hematology-Focused Investor Event
businesswire.com
BMY
Cell Therapy Market Size Set to More Than Double by 2030 -- North America Leads, While Asia-Pacific Emerges as the Fastest-Growing Region, Says Mordor Intelligence
prnewswire.com
NVS
BMY
JNJ
SRPT
GILD
TMO
DHR
SART
MRK
BDX
Global FSHD Innovation Hub Expands Board to Strengthen Leadership and Impact
prnewswire.com
BMY
BAY
ECL
LXU
AKZA
FUL
Prostate Cancer Drugs Market to Reach USD 28.10 Billion by 2033 | According to DataM Intelligence
prnewswire.com
BIIB
MRK
JNJ
PFE
AZN
BMY
GILD
EXEL
RDVY
CRIS
VRTX
INCY
ABBV
LULU
VIR
FGEN
HALD
OMP邁阿密大會2025：透過人機協同，將供應鏈願景轉化為實際影響
accessnewswire.com
AZN
BMY
EL
JNJ
KHC
ECL
BEI
MSFT
The Lanier Law Firm Supporting State in Litigation Alleging Deceptive Marketing of Blood Thinner Plavix
businesswire.com
BMY
Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies
businesswire.com
EDIT
NTLA
BMY
AZN